| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12035-014-8798-2 |
| P698 | PubMed publication ID | 24973145 |
| P2093 | author name string | Nan Wang | |
| XiaoMin Li | |||
| GuangFen Zhang | |||
| JianJun Yang | |||
| LiLi Qiu | |||
| WenXue Liu | |||
| XiaoYu Liu | |||
| ZhiQiang Zhou | |||
| ZhiYi Zuo | |||
| P2860 | cites work | Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice | Q38809906 |
| Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis | Q42497540 | ||
| Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine. | Q42750058 | ||
| Rat cortical synaptosomes have more than one mechanism for Ca2+ entry linked to rapid glutamate release: studies using the Phoneutria nigriventer toxin PhTX2 and potassium depolarization | Q42831665 | ||
| Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test | Q43128523 | ||
| Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin. | Q43249761 | ||
| Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia | Q44466191 | ||
| Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia | Q44926297 | ||
| Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity | Q45180509 | ||
| [Development of animal models for schizophrenia based on clinical evidence: expectation for psychiatrists]. | Q45948339 | ||
| Phoneutria spider toxins block ischemia-induced glutamate release, neuronal death, and loss of neurotransmission in hippocampus | Q46049330 | ||
| Edaravone (MCI-186) scavenges reactive oxygen species and ameliorates tissue damage in the murine spinal cord injury model | Q46184515 | ||
| Properties of excitatory synaptic responses in fast-spiking interneurons and pyramidal cells from monkey and rat prefrontal cortex | Q46610741 | ||
| Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens | Q46981597 | ||
| Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus | Q46989886 | ||
| Sex differences in the antidepressant-like effects of ketamine | Q48097114 | ||
| Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors | Q48099473 | ||
| Intravenous ketamine compared with diclofenac suppository in suppressing acute postoperative pain in women undergoing gynecologic laparoscopy | Q48163527 | ||
| Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression | Q48255836 | ||
| Different pattern of changes in calcium binding proteins immunoreactivity in the medial prefrontal cortex of rats exposed to stress models of depression | Q48646615 | ||
| Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex | Q48728126 | ||
| A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia | Q61713924 | ||
| Amphetamine induces hydroxyl radical formation in the striatum of rats | Q73932128 | ||
| Expression of calbindin-D28k and parvalbumin during development of rat's basolateral amygdaloid complex | Q73964600 | ||
| Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial | Q24629398 | ||
| The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine | Q28276943 | ||
| The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
| Cortical inhibitory neurons and schizophrenia | Q29547683 | ||
| A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression | Q29617914 | ||
| mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists | Q29618120 | ||
| Parvalbumin neurons and gamma rhythms enhance cortical circuit performance | Q29619163 | ||
| Animal models of neuropsychiatric disorders | Q29619899 | ||
| NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses | Q30471587 | ||
| Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials | Q30998754 | ||
| Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. | Q33186255 | ||
| Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine | Q33247010 | ||
| Dizocilpine (MK-801) induces distinct changes of N-methyl-D-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex | Q33444363 | ||
| Animal models of depression: molecular perspectives | Q34158534 | ||
| Ketamine* | Q34171927 | ||
| NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons | Q34197064 | ||
| Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase | Q34722527 | ||
| Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure | Q34744471 | ||
| Mitochondrial regulation of NADPH oxidase in hindlimb unweighting rat cerebral arteries | Q35156003 | ||
| Functional synergism between putative gamma-aminobutyrate-containing neurons and pyramidal neurons in prefrontal cortex | Q35210835 | ||
| Signaling pathways underlying the rapid antidepressant actions of ketamine | Q35375293 | ||
| Nicotine improves working memory span capacity in rats following sub-chronic ketamine exposure | Q35592077 | ||
| Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study | Q35892768 | ||
| Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression | Q36128314 | ||
| Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants | Q36756087 | ||
| Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex | Q36852122 | ||
| Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond | Q36899381 | ||
| The acute effects of NMDA antagonism: from the rodent to the human brain | Q37243491 | ||
| A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia | Q37369353 | ||
| Are we getting closer to valid translational models for major depression? | Q38050124 | ||
| Spinal sigma-1 receptors activate NADPH oxidase 2 leading to the induction of pain hypersensitivity in mice and mechanical allodynia in neuropathic rats | Q38449808 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 808-819 | |
| P577 | publication date | 2014-06-28 | |
| P1433 | published in | Molecular Neurobiology | Q15716645 |
| P1476 | title | Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administration | |
| P478 | volume | 51 |
| Q47789718 | Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242. |
| Q98564486 | Dementia-Related Psychosis and the Potential Role for Pimavanserin |
| Q41578594 | Hippocampal Perineuronal Nets Are Required for the Sustained Antidepressant Effect of Ketamine |
| Q89992151 | Ketamine relieves depression-like behaviors induced by chronic postsurgical pain in rats through anti-inflammatory, anti-oxidant effects and regulating BDNF expression |
| Q42257146 | Ketamine: differential neurophysiological dynamics in functional networks in the rat brain |
| Q47610910 | NOX2 Mediated-Parvalbumin Interneuron Loss Might Contribute to Anxiety-Like and Enhanced Fear Learning Behavior in a Rat Model of Post-Traumatic Stress Disorder |
| Q90375185 | Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin |
| Q90141029 | Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies |
| Q35054539 | Recent insights into the mode of action of memantine and ketamine |
| Q47633542 | Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression. |
| Q50507575 | Repeated Neonatal Sevoflurane Exposure-Induced Developmental Delays of Parvalbumin Interneurons and Cognitive Impairments Are Reversed by Environmental Enrichment. |
| Q94550971 | Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine |
| Q89531770 | Sepsis induced cognitive impairments by disrupting hippocampal parvalbumin interneuron-mediated inhibitory network via a D4-receptor mechanism |
| Q30278606 | Sepsis-induced selective parvalbumin interneuron phenotype loss and cognitive impairments may be mediated by NADPH oxidase 2 activation in mice |
| Q42109374 | Structural Integrity in the Sustained Antidepressant Effect of Ketamine |
| Q47382890 | The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders |
| Q47615302 | Toxicological analysis and antihyperalgesic, antidepressant, and anti-inflammatory effects of Campomanesia adamantium fruit barks |
Search more.